Sulzer Hip, Knee Surgery Patients Would Be Compensated By Profits, Insurer

Sulzer Medica is proposing to use one-half of its annual net income to help finance a nearly $100,000 cash-and-equity compensation package for hip-and-knee implant patients requiring multiple revision surgeries over the next three to five years.

More from Archive

More from Medtech Insight